Elevated Thyrotropin Levels Associated With Severe Depression
Severe depression is associated with higher thyrotropin levels, according to results of a historical cohort study conducted at the University of Utah.
All articles by Psychiatry Advisor Contributing Writer
Pharmacogenetics in Antidepressant Selection for Major Depressive Disorder
Presently, clinicians should be urged to view genetics as an additional tool in choosing prescriptions for MDD, as opposed to a replacement for complete clinical evaluation.
Bidirectional Association of Alopecia Areata and Depression Found in Siblings
Shared familial mechanisms may underlie alopecia areata and major depressive disorder, and suggest a bidirectional association.
Adverse Childhood Experiences Linked to Childhood Atopic Dermatitis
Adverse childhood experience, particularly the occurrence of multiple experiences including physical or emotional abuse, are associated with increased chance of atopic dermatitis.
Increased Risk for Anxiety and Depression in Ankylosing Spondylitis
Researchers reviewed the incidence and determinants of depression and/or anxiety in patients with ankylosing spondylitis.
Anxiety and Depression Higher in Patients With Acne Vulgaris
As patients with acne often have psychological comorbidities a multidisciplinary approach may yield optimal treatment.
Scoring Analysis Detects Genetic Correlation Between Osteoporosis and Schizophrenia
Researchers explored the genetic correlation between schizophrenia and osteoporosis.
Oseltamivir Not Linked to Increased Risk for Neuropsychiatric Events
No difference was seen in the risk for serious neuropsychiatric events in patients who received oseltamivir in the 30 days after influenza diagnosis compared with those who did not.
Can Vortioxetine Ameliorate SSRI-Induced Sexual Dysfunction in Well-Treated MDD?
Switching to vortioxetine appears to be a safe and effective alternative for patients experiencing sexual dysfunction during antidepressant therapy with a selective serotonin reuptake inhibitor.
Anticonvulsant Ethosuximide Fails to Elicit Antidepressant Effect in MDD
It is unlikely that ethosuximide elicits ketamine-like rapid-acting antidepressant actions in patients with major depressive disorder.
-
Loading...
-
Loading...
Next post in Depression Advisor
